Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

BADALAMENTI, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.693
EU - Europa 8.160
AS - Asia 6.965
SA - Sud America 1.145
AF - Africa 236
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 14
Totale 31.241
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.390
SG - Singapore 2.663
RU - Federazione Russa 2.260
IT - Italia 1.689
CN - Cina 1.606
DE - Germania 943
BR - Brasile 929
FI - Finlandia 849
HK - Hong Kong 679
VN - Vietnam 641
UA - Ucraina 456
PL - Polonia 446
GB - Regno Unito 365
BD - Bangladesh 346
FR - Francia 320
JP - Giappone 247
IE - Irlanda 236
IN - India 166
CA - Canada 141
KR - Corea 140
NL - Olanda 121
SE - Svezia 117
IQ - Iraq 84
MX - Messico 74
AR - Argentina 72
AT - Austria 66
TR - Turchia 66
BE - Belgio 60
RO - Romania 59
ES - Italia 56
ZA - Sudafrica 51
MA - Marocco 41
IR - Iran 35
UZ - Uzbekistan 35
EC - Ecuador 32
CI - Costa d'Avorio 31
PK - Pakistan 31
CL - Cile 30
ID - Indonesia 29
AU - Australia 28
KE - Kenya 27
JM - Giamaica 25
TN - Tunisia 23
VE - Venezuela 23
JO - Giordania 22
AE - Emirati Arabi Uniti 21
CO - Colombia 20
NP - Nepal 19
SA - Arabia Saudita 19
EG - Egitto 18
MY - Malesia 18
DZ - Algeria 17
LT - Lituania 16
BG - Bulgaria 14
KZ - Kazakistan 13
PH - Filippine 13
PY - Paraguay 13
CH - Svizzera 12
UY - Uruguay 12
AL - Albania 11
CZ - Repubblica Ceca 11
CR - Costa Rica 10
HN - Honduras 10
OM - Oman 10
DO - Repubblica Dominicana 8
GR - Grecia 8
PE - Perù 8
EU - Europa 7
LB - Libano 7
PT - Portogallo 7
AZ - Azerbaigian 6
BO - Bolivia 6
NI - Nicaragua 6
SV - El Salvador 6
TT - Trinidad e Tobago 6
BA - Bosnia-Erzegovina 5
BH - Bahrain 5
BY - Bielorussia 5
GE - Georgia 5
MD - Moldavia 5
MM - Myanmar 5
PA - Panama 5
CY - Cipro 4
DK - Danimarca 4
ET - Etiopia 4
IL - Israele 4
LV - Lettonia 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
AO - Angola 3
EE - Estonia 3
GH - Ghana 3
HU - Ungheria 3
KG - Kirghizistan 3
ML - Mali 3
MN - Mongolia 3
NO - Norvegia 3
PS - Palestinian Territory 3
SN - Senegal 3
TW - Taiwan 3
Totale 31.197
Salva come PNG Salva come JPEG
Città #
Ashburn 1.904
Singapore 1.653
Fairfield 1.370
San Jose 955
Chandler 744
Woodbridge 737
Houston 683
Hong Kong 648
Wilmington 600
Seattle 518
Ann Arbor 473
Cambridge 426
Moscow 417
Palermo 381
Zgierz 377
Council Bluffs 323
Beijing 287
Dallas 286
Helsinki 272
Jacksonville 249
Los Angeles 248
New York 240
Tokyo 238
Medford 234
Ho Chi Minh City 231
Dublin 229
Santa Clara 214
Boardman 207
Des Moines 201
Frankfurt am Main 191
The Dalles 183
Lauterbourg 174
Hefei 164
Hanoi 147
Princeton 144
Rome 144
Altamura 127
San Diego 124
Munich 114
Buffalo 113
Lawrence 112
Nanjing 109
São Paulo 106
Chicago 101
Ludwigshafen am Rhein 83
Orem 75
Milan 74
Dearborn 70
London 70
Tulsa 67
Nuremberg 61
Brussels 55
Seoul 55
Jinan 50
Warsaw 50
Montreal 48
Phoenix 47
Lappeenranta 45
Atlanta 44
Changsha 44
Tianjin 44
Amsterdam 42
Denver 39
Brooklyn 38
Kitzingen 38
Nanchang 38
Rio de Janeiro 36
Shenyang 35
Bremen 34
Johannesburg 34
Vienna 34
Chennai 33
Guangzhou 32
Abidjan 31
Baghdad 30
Haiphong 30
Naples 30
Toronto 30
Da Nang 29
Hebei 28
Kumar 26
Poplar 26
Manchester 25
San Francisco 25
Tashkent 25
Turin 25
Jiaxing 24
Pune 23
Falls Church 22
Nairobi 22
Amman 21
Columbus 21
Saint Petersburg 21
San Paolo di Civitate 21
Seongnam 21
Hangzhou 20
Mumbai 20
Redwood City 20
Venice 20
Boston 19
Totale 19.468
Salva come PNG Salva come JPEG
Nome #
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily). 416
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 408
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials 327
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study 319
Activin A circulating levels in patients with bone metastasis from breast or prostate cancer 306
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features 299
Founder mutations in BRCA1 and BRCA2 genes 299
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 287
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer. 283
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma 277
One shot NEPA plus dexamethasone to prevent multiple-day chemotherapy in sarcoma patients 275
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis 269
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers 264
Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosis. 260
Ductal lavage: a valid method of risk assessment and of early diagnosis in breast cancer. 258
Antiemetic prophylaxis containing Palonosetron (P) alone or in combination with Aprepitant (A) in the treatment of advanced soft tissue sarcoma (STS) patients with epirubicin and ifosfamide 258
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma 257
A case of squamocellular uterine cervix carcinoma metastatic to the skin with enterocutaneous fistula. 256
A case of guillain-barre syndrome in a patient with non small cell lung cancer treated with chemotherapy 255
Ductal lavage: a way of carefully tracing the breast-secreting duct 255
Surgical Treatment of Extravasation Injuries 252
MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone. 252
The role of Aurora-A inhibitors in cancer therapy. 252
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial. 249
Lack of Correlation between Liver Tests Abnormalities and Trabectedin Efficacy in the Treatment of Soft Tissue Sarcoma: A Retrospective Study 243
Dedifferentiated retroperitoneal large liposarcoma and laparoscopic treatment: Is it possible and safe? The first literature case report 242
Beyond evidence-based data: Scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma 240
P16 ink4A, p53 alterations and S phase fraction are predictive of clinical outcome in laryngeal squamous cell carcinoma. 235
Cardiovascular Toxicity in Cancer Patients Treated with Tyrosine Kinase Inhibitors: A Real-World Single-Center Experience 232
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice 230
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients 230
Bone metastases in patients with metastatic renal cell carcinoma: Are they always associated with poor prognosis? 229
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysis 228
Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysis 227
Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary Report 225
Ductal Lavage: a valid method of risk assessment and of early diagnosis in breast cance 223
A “lymphocyte microrna signature” as predictive biomarker of immunotherapy response and plasma pd-1/pd-l1 expression levels in patients with metastatic renal cell carcinoma: Pointing towards epigenetic reprogramming 222
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 219
Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions 218
A phase II study of capecitabine oxaliplatin chemotherapy in metastatic breast cancer patients pretreated with anthracyclines and taxanes 216
PML expression in soft tissue sarcoma: Prognostic and predictive value in alkylating agents/antracycline-based first line therapy. 215
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases 215
A single-institution retrospective analysis of metachronous and synchronous metastatic bronchial neuroendocrine tumors 215
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 215
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer 214
Serum follistatin in patients with prostate cancer metastatic to the bone 210
CT and MR imaging of chemotherapy-induced hepatopathy 210
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers 209
Fatal heart failure induced by pazopanib in a sarcoma patient previously treated with gemcitabine 209
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes 208
Effects of zoledronic acid on proteinase plasma levels in patients with bone metastases. 207
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) 207
Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study. 205
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis 205
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 200
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1 199
Evaluation of predictive factors for i-CLARAS (intraoperative complications in laparoscopic renal and adrenal surgery): a multicentre international retrospective cohort study 198
Activin A and matrix metalloproteinase -2 and -9 blood levels as gauges of bone metastatic spread 198
ACTIVIN A CIRCULATING LEVELS IN PATIENTS WITH PRIMARY OSTEOPOROSIS OR BONE METASTASES FROM BREAST CANCER 198
Persistance of residual vein thrombosis after an episode of deep vein thrombosis of the lower limbs and the risk of new cancer and cardiovascular disease. 197
Serum interleukin-6 in patients with metastatic bone disease: correlation with cystatin C. 197
Bone metastases in soft tissue sarcoma: a survey of natural history, prognostic value and treatment options 197
Activin A circulating levels in patients with osteoporosis or bone metastasis from breast cancer 196
Low dose oral chemotherapy for hormone refractory prostate carcinoma estramustine phosphate versus estramustine phosphate and etoposide. A Randomized phase II study of GSTU foundation 191
Soft tissue sarcomas in the precision medicine era: new advances in clinical practice and future perspectives 191
18F-Fluorodeoxyglucose Uptake in PDGFRA-Mutant Gastrointestinal Stromal Tumors 187
Anticancer therapy-induced vascular toxicity: VEGF inhibition and beyond 187
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma? 187
A phase II study of Oxaliplatin Capecitabine chemotherapy in metastatic breast cancer patients pretreated with anthracyclines and taxanes 186
Surgical treatment of primary gastrointestinal stromal tumors (GISTs): Management and prognostic role of R1 resections 186
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer. Proceeding of ICACT Fifteenth International Congress on Anticancer Treatment February 9th 12th 2004, Paris accepted for oral presentation 184
Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors 183
Exploring the potential of multiomics liquid biopsy testing in the clinical setting of lung cancer 182
Activin A circulating levels in Patients with primary osteoporosis or bone metastases from brest cancer 181
Effects of Zoledronic Acid on Cathepsin K circulating levels in patients with bone metastasis. 181
Cardiotossicità e Cardioprotezione. 181
Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey. 181
Gists eredo familiari e pediatrici: aspetti biomolecolari e clinici. 180
Lenograstim in preventing chemotherapy-induced febrile neutropenia in patients with soft tissue sarcoma 180
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? 178
Into the wild of long non-coding RNA in gastrointestinal stromal tumors (GISTs) to explore new prognostic/predictive biomarkers 177
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs) 177
A phase 2 study of Oxaliplatin ( O ) – Capecitabine( C ) chemotherapy in metastatic breast cancer ( MBC ) patients pretreated with Anthracyclines and taxanes VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 176
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study 174
Delaying surgery for patients with a previous SARS-CoV-2 infection 173
Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study 173
New potential circulating markers for the therapeutic monitoring of metastatic bone disease. 172
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic 172
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone? 168
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas 167
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 167
Safety and effectiveness of gemcitabine for the treatment of classic Kaposi’s sarcoma without visceral involvement 164
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay 162
Weekly Paclitaxel (T) and pegylated liposomal Doxorubicin (PLD) as first line treatment in metastatic breast cancer (MBC) patients.VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 162
Activin a and matrix metalloproteinase-2 and -9 blood levels as gauges of bone metastatic spread. In: Tumor microenvironment:Heterotypic interactions. 160
Duodenal perforation as presentation of gastric neuroendocrine tumour: A case report 159
Pegylated Liposomal Doxorubicin and weekly paclitaxel as first line treatment in metastatic breast cancer 157
The use of pegylated liposomal doxorubicin (PLD) in association with weekly paclitaxel as second line therapy in metastatic bladder carcinoma: final results 156
Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors 155
Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. “Re-discovering the neglected biosources of the liquid biopsy family” 154
Totale 21.667
Salva come PNG Salva come JPEG
Categoria #
all - tutte 112.383
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.383
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.900 103 339 77 61 86 75 98 107 189 254 156 355
2022/20232.474 272 491 70 274 226 347 180 203 233 22 94 62
2023/20241.307 51 142 98 107 90 229 185 100 25 42 30 208
2024/20254.015 100 228 232 303 150 238 407 335 266 484 498 774
2025/202613.984 1.040 420 1.003 1.237 1.445 1.934 1.815 1.298 1.120 1.376 678 618
2026/2027349 349 0 0 0 0 0 0 0 0 0 0 0
Totale 32.230